Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BrainCool

0.52 SEK

+0.58 %

Less than 1K followers

BRAIN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.58 %
-8.96 %
-43.16 %
-65.57 %
-60.68 %
-62.18 %
-67.08 %
-87.40 %
-70.57 %

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

Read more
Market cap
175.68M SEK
Turnover
30.56K SEK
Revenue
39.96M
EBIT %
-105.58 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11/2
2026

Annual report '25

All
Webcasts
Press releases
ShowingAll content types
Press release6 hours ago

BioStock: BioStock Investor Pitch: BrainCool

BrainCool
Press release12/4/2025, 10:01 AM

BioStock: BrainCools vd kommenterar tillväxt och emission

BrainCool
Regulatory press release12/1/2025, 2:53 PM

BrainCool publishes information document regarding rights issue

BrainCool

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release12/1/2025, 2:53 PM

BrainCool offentliggör informationsdokument avseende företrädesemission

BrainCool
Regulatory press release11/26/2025, 11:35 AM

Kommuniké från extra bolagsstämma i BrainCool

BrainCool
Regulatory press release11/26/2025, 11:35 AM

Communiqué from extraordinary general meeting in BrainCool

BrainCool
Regulatory press release10/29/2025, 7:00 AM

PRINCESS 2 med BrainCools produkt RhinoChill® System uppmärksammad vid möte för European Resuscitation Guidelines

BrainCool
Regulatory press release10/27/2025, 7:00 AM

BrainCool stärks av uppdaterade riktlinjer i USA för medicinsk precisionskylning vid plötsligt hjärtstopp

BrainCool
Regulatory press release10/24/2025, 6:40 AM

BrainCool AB (publ) - Delårsrapport Q3 2025

BrainCool
Regulatory press release10/24/2025, 6:05 AM

KALLELSE TILL EXTRA BOLAGSSTÄMMA I BRAINCOOL AB (PUBL)

BrainCool
Regulatory press release10/24/2025, 6:05 AM

NOTICE OF EXTRA GENERAL MEETING IN BRAINCOOL AB (PUBL)

BrainCool
Regulatory press release10/24/2025, 6:00 AM

BrainCool genomför en företrädesemission om cirka 42 MSEK som fullt ut omfattas av teckningsåtaganden och tidigarelägger publicering av Q3-rapport

BrainCool
Regulatory press release10/24/2025, 6:00 AM

BrainCool carries out a rights issue of approximately SEK 42 million which is fully covered by subscription undertakings and advances publication of Q3 report

BrainCool
Regulatory press release10/20/2025, 6:00 AM

BrainCool meddelar att ansökan om marknadsgodkännande för IQool™ System lämnats in i Japan

BrainCool
Regulatory press release10/15/2025, 6:00 AM

BrainCool uppnår ytterligare milstolpe i sitt kostnadsoptimeringsprogram

BrainCool
Regulatory press release9/25/2025, 7:15 AM

BrainCools kliniska partner erhåller projektbidrag om SEK 1,3 miljoner för klinisk valideringsstudie

BrainCool
Regulatory press release9/16/2025, 4:30 PM

BrainCool inleder rekrytering av ny vd

BrainCool
Regulatory press release9/4/2025, 6:00 AM

BrainCool deltar vid DSG25 Deutscher Schlaganfallkongress

BrainCool
Press release8/26/2025, 6:00 AM

BrainCool deltar vid Aktiedagarna i Stockholm

BrainCool
Regulatory press release8/15/2025, 6:00 AM

BrainCool AB (publ) - Financial Report for Q2 2025

BrainCool
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.